~~<i id='C87122DD44'><strike id='C87122DD44'><tt id='C87122DD44'><pre id='C87122DD44'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：explore 2025-09-06 02:03:45 - browse：11747

Allergan, Dom Smith/STAT

It wasn’t supposed to work out this way for Brent Saunders.

Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： ASCO: AstraZeneca says CAR

hotspot

focus

Wikipedia

hotspot

focus

knowledge

AdobeCHICAGO—Anext-generationCAR-Ttherapywasabletosubstantiallyshrinktumorsinpatientswithlivercancer

WSS

Scientists unlock the key to scar

FDA does about

BMI, flaws aside, is found to be useful estimate of body fat in youth

House looks to weaken Medicare negotiation

Pfizer highlights cancer drugs it thinks could reignite investor interest

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

focus

hotspot

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Kenai launches with $82 million for Parkinson’s stem cell therapy

How one medical school became remarkably diverse

Shifting the focus from loneliness to social health

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Flu vaccine offering decent levels of protection this winter, new data show

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In search for therapies for solid tumors, companies turn to claudin

Heart attack and stroke risk calculators need revising

Flu vaccine offering decent levels of protection this winter, new data show

focus

BMI, flaws aside, is found to be useful estimate of body fat in youth

House looks to weaken Medicare negotiation

Medical device lobby: We're tired of waiting on Medicare coverage

The Pandemic Treaty must support building strong health systems

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Wikipedia

hotspot

focus

knowledge